Results 321 to 330 of about 1,173,658 (399)
Evaluating effectiveness and comparative costs of hepatitis C virus self-testing service delivery models in Vietnam: A cross-sectional study. [PDF]
PLOS Glob Public HealthNgoc BV, Hung MT, Thu HPT, Trong KN, Mai HN, Do Tuan K, Le Thanh AN, Huong LTT, Khanh AT, Le Thu G, Van CP, Granger K, Hatzold K, Dunkley Y, Johnson CC, Luhmann N, Green K. +16 moreeuropepmc +1 more sourceOver one‐third of cancer cases and two‐fifths of cancer deaths in southern China are preventable: Insights from the latest representative population‐based cancer registry data and risk factor survey
International Journal of Cancer, EarlyView.What's New?
This study quantified the cancer burden attributable to modifiable risk factors in Guangdong, the most populous and economically advanced province in southern China. By evaluating 15 modifiable risk factors, the study reveals that over one‐third of cancer cases and two‐fifths of cancer deaths in the region could potentially be prevented ...Xiaolan Wen, Yu Liao, Jiayue Li, Qian Zhu, Xinmei Lin, Bingfeng Han, Li Li, Ru Chen, Ruilin Meng, Ni Xiao, Xueyan Zheng, Xiaojun Xu, Dejian Zhao, Yue Gao, Liming Pu, Ye Wang, Wenqiang Wei, Shaoming Wang +17 morewiley +1 more sourceReceptor transporter protein 4 (RTP4)-mediated repression of hepatitis C virus replication in mouse cells. [PDF]
PLoS PathogSchwoerer MP, Carver S, Lin AE, Liu J, Cafiero TR, Berggren KA, Dhawan S, Suzuki S, Heller B, Rodriguez C, O'Connell AK, Gertje HP, Crossland NA, Ploss A. +13 moreeuropepmc +1 more sourceLinkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits
International Journal of Cancer, EarlyView.What's New?
Hepatocellular carcinoma arises from a combination of environmental and genetic factors, with the latter playing a potentially more significant role in nonviral hepatocellular carcinoma. Here, the authors characterized the genetic correlations and heritability between nonviral hepatocellular carcinoma and 901 epidemiologic, behavioral, and ...Younghun Han, Vikram R. Shaw, Jinyoung Byun, Aaron P. Thrift, Catherine Zhu, Donghui Li, Rikita I. Hatia, Robin Kate Kelley, Sean P. Cleary, Anna S. Lok, Paige M. Bracci, Jennifer B. Permuth, Roxana Bucur, Jennifer Knox, Jian‐Min Yuan, Amit G. Singal, Prasun K. Jalal, R. Mark Ghobrial, Yuko Kono, Dimpy P. Shah, Mindie H. Nguyen, Neehar D. Parikh, Richard Kim, Hui‐Chen Wu, Hashem El‐Serag, Ping Chang, Yun Shin Chun, Jian Gu, Chad Huff, Asif Rashid, Lu‐Yu Hwang, Alison P. Klein, Saira A. Khaderi, Ahmed O. Kaseb, Kathrine A. McGlynn, Lewis R. Roberts, Manal M. Hassan, Christopher I. Amos +37 morewiley +1 more sourceRestoration of the gut-microbiota-liver axis after hepatitis C virus eradication. [PDF]
JHEP RepInoue T, Nakayama J, Mori H, Tanaka M, Nakagawa D, Ohnishi M, Funatsu Y, Moriya K, Kawaratani H, Watanabe H, Suda G, Kondo Y, Ide T, Kakizaki S, Miuma S, Suetsugu A, Kawata K, Watanabe T, Iio E, Momoda R, Suzuki Y, Sakamaki A, Watanabe T, Watanabe T, Nagaoka K, Hiasa Y, Terai S, Yoshiji H, Toyoda A, Kurokawa K, Tanaka Y. +30 moreeuropepmc +1 more sourcePre‐diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case–control analysis of 12 prospective cohorts
International Journal of Cancer, EarlyView.What's New?
Disruption of the gut–liver axis has been suggested to play an important role in liver carcinogenesis. However, limited prospective research has explored associations between potentially harmful gut‐derived bacterial products and liver cancer risk.Cody Z. Watling, Peter T. Campbell, Barry I. Graubard, Yanyu Wang, Andrew T. Gewirtz, Xuehong Zhang, Matthew J. Barnett, Julie E. Buring, Yu Chen, A. Heather Eliassen, J. Michael Gaziano, Jonathan N. Hofmann, Wen‐Yi Huang, Jae H. Kang, Jill Koshiol, Erikka Loftfield, I‐Min Lee, Steven C. Moore, Lorelei A. Mucci, Marian L. Neuhouser, Christina C. Newton, Mark P. Purdue, Howard D. Sesso, Martha Shrubsole, Rashmi Sinha, Lesley Tinker, Matthew Triplette, Caroline Y. Um, Kala Visvanathan, Eleanor L. Watts, Jean Wactawski‐Wende, Walter Willett, Fen Wu, Wei Zheng, Dinesh Barupal, Jessica L. Petrick, Katherine A. McGlynn +36 morewiley +1 more sourceControlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated women
International Journal of Cancer, EarlyView.What's New?
Since the introduction of the human papillomavirus (HPV) vaccine in 2006, vaccine‐type infections have declined markedly. As nonvaccine HPV types generally carry lower oncogenic potential, this shift warrants reevaluation of cervical screening regimens.Mònica Ortega Llobet, Penelope Gray, Iacopo Baussano, K. Miriam Elfström, Tiina Eriksson, Camilla Lagheden, Pekka Nieminen, Anna Söderlund‐Strand, Joakim Dillner, Ville N. Pimenoff, Matti Lehtinen +10 morewiley +1 more sourceCancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV
International Journal of Cancer, EarlyView.What's New?
This large nation‐wide cohort study provides a comprehensive 20‐year analysis of cancer trends among people living with HIV in France, highlighting persistent excess risks for virus‐related cancers despite effective antiretroviral therapy and immune restoration.Sophie Grabar, Paula Lakrout, Valérie Potard, Aurélien Belot, Jacques Cadranel, Christine Jacomet, Christine Katlama, Esaïe Marshall, Olivier Lambotte, Romain Palich, Sylvie Ronot‐Bregigeon, Jean‐Philippe Spano, Anne‐Marie Bouvier, Alain Makinson, Dominique Costagliola +14 morewiley +1 more source